ckd-333
Small moleculeexperimental
Clinical trial activity
6 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 8, 2018 (NCT03659149)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04627207 | Phase 1 | Nov 30, 2020 | Chong Kun Dang Pharmaceutical, Chungnam National University |
| NCT04611932 | Phase 1 | Nov 11, 2020 | Chong Kun Dang Pharmaceutical |
| NCT04478097 | Phase 1 | Jul 14, 2020 | Chong Kun Dang Pharmaceutical |
| NCT04019743 | Phase 1 | Jul 29, 2019 | Chong Kun Dang Pharmaceutical |
| NCT03849287 | Phase 1 | Feb 25, 2019 | Catholic University of Korea, Chong Kun Dang Pharmaceutical |
| NCT03659149 | Phase 1 | Aug 8, 2018 | Catholic University of Korea, Chong Kun Dang Pharmaceutical |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chong Kun Dang Pharmaceutical | For profit | 6 | 6 | 1 | 2018 |
| Catholic University of Korea | Academic/Hospital | 2 | 0 | 1 | 2018 |
| Chungnam National University | Academic/Hospital | 1 | 0 | 1 | 2020 |
3 organizations
Page 1 / 1